ZOM stock DD amp Technical analysis Stock overview Updated 15 Nov

>> YOUR LINK HERE: ___ http://youtube.com/watch?v=10jfyd70WIQ

My educational series videos for reading charts = • Stocks Educational Series • Full longterm DD on this stock : • $NIO short Long term stock DD - Sto... • Zomedica Pharmaceuticals Corp., a development stage veterinary diagnostic and pharmaceutical company, engages in the discovery, development, and commercialization of pharmaceuticals for the companion pet. Its lead drug product candidate is ZM-007, an oral suspension formulation of metronidazole for the treatment of acute diarrhea in small dog breeds and puppies. The company is also developing ZM-012, a tablet formulation of metronidazole targeting the treatment of acute diarrhea in dogs; ZM-006, a transdermal gel formulation of methimazole targeting hyperthyroidism in cats; and ZM-011, a transdermal gel formulation of fluoxetine for the treatment of feline behavioral disorders, such as inappropriate urination. It has a collaboration agreement with Celsee Diagnostics, Inc. for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals; and with Seraph Biosciences, Inc. for development and commercialization of novel pathogen detection system. The company was founded in 2015 and is headquartered in Ann Arbor, Michigan. • Website :https://zomedica.com/ • Twitter : / ferocioused • PlatSharpTradez Discord : / discord • Questrade referral code: 426033354436861 • Music by Youtube music library

#############################

New on site